Searchable abstracts of presentations at key conferences in endocrinology

ea0014oc1.7 | Thyroid clinical | ECE2007

Pregnant women on thyroxine substitution are often dysregulated in early pregnancy

Hallengren Bengt , Lantz Mikael , Andreasson Bengt , Grennert Lars

Background: Thyroid hormones are important for normal fetal development. The aim of this prospective study was to explore whether thyroxine treated pregnant women with hypothyroidism are adequately thyroxine substituted during pregnancy.Material and method: During the years 1997–2002 119 pregnancies in 101 females with thyroid diseases were followed at the Department of Endocrinology. The diagnoses were autoimmune thyroiditis (AIT) with or without h...

ea0056p790 | Pituitary - Clinical | ECE2018

Final results of NordiNet® international outcome study: key outcomes

Savendahl Lars , Puras Gediminas , Pedersen Birgitte Tonnes , Weber Matthias

Background: The NordiNet® International Outcome Study (IOS) (NCT00960128), a non-interventional study (2006–2016), assessed the effectiveness and safety of real-life treatment with Norditropin®. Out of 20,548 enrolled patients, 20,195 (paediatric/adult; 17,711/2484) were included in the full analysis set (FAS) and 12,938 (11,967/971) in the effectiveness analysis set (EAS). Outcomes were assessed in children with growth hormone deficiency (...

ea0092op-04-03 | Oral Session 4: Young Investigators / Clinical and Translational | ETA2023

Long-Term outcome of the thyroid function in graves’ disease: a nationwide danish register study

Sophia Eriksen Anine , Folkestad Lars , Brix Thomas , Joop Bonnema Steen

Background: Little is known about the long-term outcome of the thyroid function in Graves’ disease in a large epidemiological setting.Objective: The aim was to evaluate the long-term outcome of the thyroid function in patients diagnosed with Graves’ disease in Denmark in the period 1995-2018. Our research objectives were to investigate the incidence of disease, use of antithyroid drugs, radioactive iodine, thyroidectomy and levothyroxine during...

ea0022p617 | Neuroendocrinology and Pituitary (<emphasis role="italic">Generously supported by Novartis</emphasis>) | ECE2010

Epidemiology of craniopharyngioma in Denmark 1985–2004: a 2% increase in incidence rate per year

Husted Nielsen Eigil , Feldt-Rasmussen Ulla , Poulsgaard Lars , Ostergaard Kristensen Lars , Astrup Jens , Otto Jorgensen Jens , Bjerre Per , Andersen Marianne , Andersen Claus , Jorgensen Jesper , Lindholm Jorgen , Laurberg Peter

Background: Craniopharyngioma may be associated with severe morbidity. Few data exist on incidence rate (IR) and possible changes with time. The epidemiology of craniopharyngioma in Denmark has never been evaluated in detail.Objectives: To review the literature on craniopharyngioma incidence and to study the epidemiology of craniopharyngioma in Denmark during a recent 20-year period.Material and methods: Publications including data...

ea0081rc8.3 | Rapid Communications 8: Calcium and Bone | ECE2022

What is the most efficient way to fortify food items with vitamin D? A randomised, multiple crossover study

Espersen Rasmus , Ring Madsen Lene , Nebel Caroline , Danielsen Marianne , Dalsgaard Trine , Rejnmark Lars

Introduction: Vitamin D insufficiency (25-hydroxy vitamin D <50 nmol/l) is a global health problem. Vitamin D food fortification might be the solution, but knowledge is sparse on whether fortification of various food items affects the bioavailability differently. It is generally assumed that ingesting vitamin D with a fatty meal improves the bioavailability of vitamin D. Furthermore, complex formation with whey protein isolate (WPI) may enhance the stability of vitamin D a...

ea0081rc10.4 | Rapid Communications 10: Diabetes, Obesity, Metabolism and Nutrition 3 | ECE2022

Adequate metabolic control at early stages of childhood onset type 1 diabetes prevent diabetic neuropathy: a 30 year follow up study

Baldimtsi Evangelia , Amezcua Salvador , Olausson Hakan , Ludvigsson Johnny , Hyllienmark Lars , Wahlberg Jeanette

Background and aims: Diabetic neuropathy is a common complication of type 1 diabetes. In this study we investigated the importance of long-term metabolic control for the development of diabetic neuropathy in patients with type 1 diabetes diagnosed in childhood.Materials and methods: Longitudinal cohort study. Twenty-five patients (9 women 16 men) were studied three times with neurophysiological measurements and clinical examinations. At baseline the pati...

ea0081ep982 | Thyroid | ECE2022

Association between vitamin D serum concentration and development of papillary thyroid cancer

Katalinic Darko , Aleric Ivan , Vcev Aleksandar , Solter Miljenko , Ranogajec Irena , Toetome Lars

Purpose: Papillary thyroid cancer (PTC) is the most common thyroid and endocrine malignancy worldwide. Vitamin D (calciferol or 25-hydroxyvitamin D) (25(OH)D) has been postulated as a key modulator in several cancer-related pathways, although its contribution to PTC still remain controversial. The aim of the study was to analyse the correlation between 25(OH)D serum levels and 25(OH)D insufficiency as well as the risk of development of PTC and its variants: classical type (CV-...

ea0081ep1041 | Thyroid | ECE2022

Papillary thyroid cancer and its variants - genomic evidence and clinical significance

Katalinic Darko , Aleric Ivan , Vcev Aleksandar , Solter Miljenko , Ranogajec Irena , Toetome Lars

Purpose: Papillary thyroid cancer (PTC) accounts for approximately 80% of all thyroid cancers and is defined by its unique cytologic and histologic features. Mutations of the RET and BRAF/V600 genes are found in nearly 70% of PTC cases. They are able to trigger the activation of mitogen-activated protein kinase pathways and to promote neoplastic cell proliferation. Genetic events may further lead to numerous different cell variants of PTC which may be identified via t...

ea0084op-01-02 | Oral Session 1: Topic Highlights | ETA2022

A randomized, double-blind, placebo-controlled trial of Vitamin D supplementation in patients newly diagnosed with graves’ disease

Grove-Laugesen Diana , Ebbehoj Eva , Hansen Klavs , Watt Torquil , Rejnmark Lars

Objective: Vitamin D has potential immunomodulatory effects. We studied whether vitamin D3 supplementation affects the course of Graves’ disease (GD).Methods: In a double-blind, placebo-controlled design, we randomized patients with a first time diagnosis of GD hyperthyroidism to daily supplementation with vitamin D3 70 mg (2800 IU) or placebo, as add-on to standard treatment with anti-thyroid drugs (ATD). The intervention was continued 12 months af...

ea0041ep904 | Pituitary - Clinical | ECE2016

Subarachnoid haemorrhage results in poor quality of life independent of pituitary hormone concentrations

Nagras Zainab , Klose Marianne , Poulsgaard Lars , Kosteljanetz Michael , Brennum Jannick , Feldt-Rasmussen Ulla

Introduction: Subarachnoid haemorrhage (SAH) is associated with a mortality rate of 30% and the survivors face significant morbidity including fatigue, isolation, depression and sleep disorders; factors affecting general health related quality of life (QoL). QoL is also known to be decreased in pituitary-hypothalamic insufficiency and tends to improve after treatment. SAH has been suggested to be a common cause of hypopituitarism by some whereas not by others. We aimed to inve...